Anti-TNF-α therapy was withheld in most of these cases because of the possibility of respiratory infection or severe symptoms of sarcoidosis, and in some cases systemic corticosteroid and/or anti tuberculosis therapy were tried. The gene discussed is TNF; the disease is respiratory tract infectious disorder.